2013China Modern DoctorRequires access

Clinical comparative effectiveness studies of aripiprazole and sodium valproate sustained-release tablets in the treatment of bipolar disorder manic episode

Liang Junping

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic efficacy and safety of Aripiprazole and sodium valproate manic episodes in patients with bipolar disorder given.Methods We Collected 92 cases of bipolar disorder manic episodes,they were randomly divided into two groups,the observation group(n = 46) was given aripiprazole,the control group(n = 46) was given sodium valproate sustained-release tablets,CGI-S-BP and YMRS score,efficacy and adverse events after the treatment of two groups were compared.Results(1) With treatment time of patients longer CGI-S-BP and YMRS score were lower,there were significant differences between before and after treatment(P 0.05).The difference of two groups scores in the first two weeks was statistically significant(P 0.05),there were no significant difference in two weeks after the treatment(P 0.05).(2) There were no significant difference in clinical treatment efficiency and recovery rate between observation group and control group(P 0.05).(3) There were no significant difference in the incidence of adverse reactions between observation group and control group(P 0.05).Conclusion Treatment of bipolar disorder,manic episodes in aripiprazole has considerable therapeutic effect of sodium valproate and higher security.

About this research paper

What this paper is about

Objective To investigate the therapeutic efficacy and safety of Aripiprazole and sodium valproate manic episodes in patients with bipolar disorder given.Methods We Collected 92 cases of bipolar disorder manic episodes,they were randomly divided into two groups,the observation group(n = 46) was given aripiprazole,the control group(n = 46) was given sodium valproate sustained-release tablets,CGI-S-BP and YMRS score,efficacy and adverse events after the treatment of two groups were compared.Results(1) With treatment time of patients longer CGI-S-BP and YMRS score were lower,there were significant differences between before and after treatment(P 0.05).The difference of two groups scores in the first two weeks was statistically significant(P 0.05),there were no significant difference in two weeks after the treatment(P 0.05).(2) There were no significant difference in clinical treatment efficiency and recovery rate between observation group and control group(P 0.05).(3) There were no significant difference in the incidence of adverse reactions between observation group and control group(P 0.05).Conclusion Treatment of bipolar disorder,manic episodes in aripiprazole has considerable therapeutic effect of sodium valproate and higher security.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic efficacy and safety of Aripiprazole and sodium valproate manic episodes in patients with bipolar disorder given.Methods We Collected 92 cases of bipolar disorder manic episodes,they were randomly divided into two groups,the observation group(n = 46) was given aripiprazole,the control group(n = 46) was given sodium valproate sustained-release tablets,CGI-S-BP and YMRS score,efficacy and adverse events after the treatment of two groups were compared.Results(1) With treatment time of patients longer CGI-S-BP and YMRS score were lower,there were significant differences between before and after treatment(P 0.05).The difference of two groups scores in the first two weeks was statistically significant(P 0.05),there were no significant difference in two weeks after the treatment(P 0.05).(2) There were no significant difference in clinical treatment efficiency and recovery rate between observation group and control group(P 0.05).(3) There were no significant difference in the incidence of adverse reactions between observation group and control group(P 0.05).Conclusion Treatment of bipolar disorder,manic episodes in aripiprazole has considerable therapeutic effect of sodium valproate and higher security.

Key concepts: Aripiprazole, Medicine, Bipolar disorder, Bipolar I disorder, Internal medicine, Significant difference, Incidence (geometry), Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical comparative effectiveness studies of aripiprazole and sodium valproate sustained-release tablets in the treatment of bipolar disorder manic episode — Research Paper | ScholarLens